World Health Organization Raises Warning Over Critical Shortage of Obesity Jabs
Less than a tenth of individuals who could benefit from weight-loss injections like Wegovy can access them, warns the WHO as it issues its initial guidance on the therapies.
Considering in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging broader and more equitable access to this class of drugs.
Per estimates, over two billion will be obese by 2030 unless action is taken.
"The latest guidelines affirms that excess weight is a long-term condition that can be managed with comprehensive and lifelong care," said the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and logistical bottlenecks are key barriers to broad availability to the treatments that can assist patients in reducing significant weight, says the agency.
Skinny Jab Scarcity
Even under the present most favorable outlook, the manufacturing of these medications might only reach around 100 million people – fewer than 10% of eligible patients, according to the health organization.
The guideline urges governments and firms to expand availability, through measures including patent sharing.
Exclusive production rights on a key compound – the main ingredient of Novo Nordisk's Wegovy – is scheduled to end in multiple nations in 2026.
The Way Weight-Loss Jabs Work
The injections replicate a biological compound to delay gastric emptying, curb appetite and boost satiety so people eat less.
Individuals typically start to lose weight within a few weeks of starting on the weekly injections.
Evidence suggests people may put most of the weight back on after a year of stopping the treatment, as their normal appetite return.
To be carrying excess weight raises your likelihood for experiencing medical conditions, such as diabetes, heart disease, brain attack, and specific malignancies.
Excess weight concerns people in all nations and was linked to over three and a half million fatalities worldwide in 2024, as per the health agency.
